Marksans Pharma receives UK MHRA approval for Bells Healthcare All in One Oral Solution

1 Mar 2022 , 01:33 AM

Marksans Pharma announced that UK MHRA has granted Market Authorisation to the Companys wholly owned subsidiary Bell Sons Co Druggists for Bells Healthcare All in One Oral Solution Each 20 ml dose contains Paracetamol Ph Eur 5000 mg Guaifenesin Ph Eur 2000 mg and Phenylephrine Hydrochloride Ph Eur 100 mg Therapeutic use of the product is for short term symptomatic relief of colds chills and influenza including chesty coughs This is the first generic approval by UK MHRA for the product Marksans will manufacture the products at its UK MHRA approved facility Bell Sons Co Druggists in UK